Search Results for "Smecta "

19:57 EDT 4th August 2015 | BioPortfolio

Matching Channels

None

Matching News

Ipsen reports strong sales growth in Q1 2015 and raises guidance for the year

Group sales up 11.7%1 Specialty care sales up 14.6%1 - Somatuline® up 25.0%1, driven by the launch in neuroendocrine tumors in the ...

Ipsen: 2015 Half-Year Results

Group sales up 7.9%1 driven by solid 12.0%1 growth of Specialty care, notably due to Somatuline® Core Operating Income up 3.5%, in view of the investmen...

Matching PubMed Articles

None

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement